| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.0M | -15.7% |
| Gross Profit | -$1.7M | -114.5% |
| R&D Expense | $78.4M | -11.3% |
| SG&A Expense | $66.0M | -7.5% |
| Operating Income | -$25.6M | +76.5% |
| Pre-tax Income | $14.2M | +114.2% |
| Income Tax | $13K | -35.0% |
| Net Income | $14.2M | +114.2% |
| EPS (Basic) | $0.10 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.0M | -62.5% |
| Accounts Receivable | $4.5M | +62.2% |
| Inventory | $5.3M | -44.4% |
| Current Assets | $33.5M | -43.3% |
| Total Assets | $401.1M | -3.2% |
| Current Liabilities | $62.1M | +136.8% |
| Total Liabilities | $202.2M | -35.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$137.9M | -25.2% |
| Capital Expenditures | $5.2M | -15.6% |
| Investing Cash Flow | -$5.2M | +11.3% |
| Financing Cash Flow | $119.8M | +21.6% |
| Free Cash Flow | -$143.1M | -23.1% |
| +106.7% |
| EPS (Diluted) | $0.09 | +106.0% |
| Stockholders' Equity |
| $198.9M |
| +100.1% |